These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 15892004

  • 1. Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas.
    Liu Y, Pang JC, Dong S, Mao B, Poon WS, Ng HK.
    Hum Pathol; 2005 Apr; 36(4):416-25. PubMed ID: 15892004
    [Abstract] [Full Text] [Related]

  • 2. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC, Yu Y.
    Cancer Res; 2003 Jul 15; 63(14):4174-80. PubMed ID: 12874023
    [Abstract] [Full Text] [Related]

  • 3. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
    Zhong S, Tang MW, Yeo W, Liu C, Lo YM, Johnson PJ.
    Clin Cancer Res; 2002 Apr 15; 8(4):1087-92. PubMed ID: 11948118
    [Abstract] [Full Text] [Related]

  • 4. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P, Ichimura K, Collins VP, Reifenberger G.
    Am J Pathol; 2001 Aug 15; 159(2):661-9. PubMed ID: 11485924
    [Abstract] [Full Text] [Related]

  • 5. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
    Bae SI, Lee HS, Kim SH, Kim WH.
    Br J Cancer; 2002 Jun 17; 86(12):1888-92. PubMed ID: 12085181
    [Abstract] [Full Text] [Related]

  • 6. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ, Zhang S, Guo C, Zhang S, Wang Y, Zhang D.
    Laryngoscope; 2005 Aug 17; 115(8):1395-401. PubMed ID: 16094112
    [Abstract] [Full Text] [Related]

  • 7. DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q.
    Bello MJ, Amiñoso C, Lopez-Marin I, Arjona D, Gonzalez-Gomez P, Alonso ME, Lomas J, de Campos JM, Kusak ME, Vaquero J, Isla A, Gutierrez M, Sarasa JL, Rey JA.
    Acta Neuropathol; 2004 Nov 17; 108(5):413-21. PubMed ID: 15365725
    [Abstract] [Full Text] [Related]

  • 8. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21.
    Derks S, Bosch LJ, Niessen HE, Moerkerk PT, van den Bosch SM, Carvalho B, Mongera S, Voncken JW, Meijer GA, de Bruïne AP, Herman JG, van Engeland M.
    Carcinogenesis; 2009 Jun 17; 30(6):1041-8. PubMed ID: 19329758
    [Abstract] [Full Text] [Related]

  • 9. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.
    Harden SV, Tokumaru Y, Westra WH, Goodman S, Ahrendt SA, Yang SC, Sidransky D.
    Clin Cancer Res; 2003 Apr 17; 9(4):1370-5. PubMed ID: 12684406
    [Abstract] [Full Text] [Related]

  • 10. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.
    Choy KW, Pang CP, To KF, Yu CB, Ng JS, Lam DS.
    Invest Ophthalmol Vis Sci; 2002 May 17; 43(5):1344-9. PubMed ID: 11980845
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Quantitative analysis of promoter hypermethylation in multiple genes in osteosarcoma.
    Hou P, Ji M, Yang B, Chen Z, Qiu J, Shi X, Lu Z.
    Cancer; 2006 Apr 01; 106(7):1602-9. PubMed ID: 16502411
    [Abstract] [Full Text] [Related]

  • 13. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma.
    Fukai K, Yokosuka O, Chiba T, Hirasawa Y, Tada M, Imazeki F, Kataoka H, Saisho H.
    Cancer Res; 2003 Dec 15; 63(24):8674-9. PubMed ID: 14695180
    [Abstract] [Full Text] [Related]

  • 14. Promoter hypermethylation profile of RASSF1A, FHIT, and sFRP1 in intracranial primitive neuroectodermal tumors.
    Chang Q, Pang JC, Li KK, Poon WS, Zhou L, Ng HK.
    Hum Pathol; 2005 Dec 15; 36(12):1265-72. PubMed ID: 16311119
    [Abstract] [Full Text] [Related]

  • 15. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
    Chen W, Gao N, Shen Y, Cen JN.
    J Gastroenterol Hepatol; 2010 Apr 15; 25(4):823-31. PubMed ID: 20492341
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
    Zhao W, Soejima H, Higashimoto K, Nakagawachi T, Urano T, Kudo S, Matsukura S, Matsuo S, Joh K, Mukai T.
    J Biochem; 2005 Mar 15; 137(3):431-40. PubMed ID: 15809347
    [Abstract] [Full Text] [Related]

  • 20. Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer.
    Takada H, Wakabayashi N, Dohi O, Yasui K, Sakakura C, Mitsufuji S, Taniwaki M, Yoshikawa T.
    Cancer Genet Cytogenet; 2010 Feb 15; 197(1):16-24. PubMed ID: 20113832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.